SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biogen Idec, Inc. (Massachusetts) Release: New Phase 3 Data Reinforce Long-Lasting Protection From Bleeding for Patients With Hemophilia A and B